Bismuth subcitrate potassium, metronidazole, and tetracycline and Panitumumab Intravenous
Determining the interaction of Bismuth subcitrate potassium, metronidazole, and tetracycline and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bismuth subcitrate potassium / metronidazole / tetracycline
Brand name: Pylera
Synonyms: Bismuth Subcitrate, Metronidazole, and Tetracycline
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Panixine
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Panixine DisperDose
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Panlor
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Panlor Tablet
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Panlor Tablets
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Panlor-DC
- Panitumumab Intravenous-Bismuth Subcitrate, Metronidazole, and Tetracycline
- Panitumumab Intravenous-Bismuth Subgallate
- Panitumumab Intravenous-Bismuth subsalicylate
- Panitumumab Intravenous-Bismuth Subsalicylate Chewable Tablets
- Panitumumab Intravenous-Bismuth Subsalicylate Suspension
- Panitumumab Intravenous-Bismuth Subsalicylate Tablets